$145 Million is the total value of Sio Capital Management, LLC's 32 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 62.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QTNT | Sell | QUOTIENT LTD | $17,092,000 | -5.5% | 2,185,669 | -6.3% | 11.79% | +27.6% |
| CAH | Sell | CARDINAL HEALTH INC | $10,407,000 | -21.7% | 133,937 | -21.4% | 7.18% | +5.7% |
| ATHN | Sell | ATHENAHEALTH INCput | $7,265,000 | -36.7% | 57,600 | -30.7% | 5.01% | -14.5% |
| HRC | Sell | HILL ROM HLDGS INC | $3,799,000 | -9.9% | 61,299 | -26.7% | 2.62% | +21.6% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,746,000 | +26.0% | 1,020,719 | -23.5% | 2.58% | +70.0% |
| CCXI | Sell | CHEMOCENTRYX INC | $3,708,000 | +28.5% | 613,890 | -4.5% | 2.56% | +73.5% |
| CERN | Sell | CERNER CORPput | $3,705,000 | -72.5% | 60,000 | -73.9% | 2.56% | -62.9% |
| AAAP | Sell | ADVANCED ACCELERATOR APPLICsponsored ads | $2,877,000 | +1.1% | 75,557 | -19.8% | 1.98% | +36.5% |
| ANTH | Sell | ANTHERA PHARMACEUTICALS INC | $2,839,000 | -63.8% | 901,115 | -64.5% | 1.96% | -51.1% |
| ADMP | Sell | ADAMIS PHARMACEUTICALS CORP | $2,283,000 | +19.2% | 665,455 | -2.8% | 1.57% | +60.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $2,261,000 | -15.9% | 112,497 | -44.5% | 1.56% | +13.5% |
| FWP | Sell | FORWARD PHARMA A/Ssponsored adr | $1,786,000 | -21.0% | 85,108 | -31.6% | 1.23% | +6.6% |
| OASMY | Sell | OASMIA PHARMACEUTICAL ABadr | $365,000 | -13.9% | 122,100 | -0.7% | 0.25% | +16.1% |
| IMNP | Exit | IMMUNE PHARMACEUTICALS INC | $0 | – | -197,655 | -100.0% | -0.04% | – |
| PETX | Exit | ARATANA THERAPEUTICS INC | $0 | – | -59,869 | -100.0% | -0.19% | – |
| TEAR | Exit | TEARLAB CORP | $0 | – | -635,442 | -100.0% | -0.21% | – |
| THLD | Exit | THRESHOLD PHARMACEUTICAL INC | $0 | – | -1,333,490 | -100.0% | -0.43% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCput | $0 | – | -56,800 | -100.0% | -0.87% | – |
| Q | Exit | QUINTILES TRANSNATIO HLDGS I | $0 | – | -28,541 | -100.0% | -0.95% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -10,000 | -100.0% | -0.95% | – |
| TNET | Exit | TRINET GROUP INC | $0 | – | -122,563 | -100.0% | -1.30% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -405,374 | -100.0% | -1.32% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -37,419 | -100.0% | -1.41% | – |
| ABT | Exit | ABBOTT LABScall | $0 | – | -70,000 | -100.0% | -1.41% | – |
| CELG | Exit | CELGENE CORPput | $0 | – | -35,000 | -100.0% | -1.76% | – |
| ECL | Exit | ECOLAB INCput | $0 | – | -30,000 | -100.0% | -1.82% | – |
| NVO | Exit | NOVO-NORDISK A Sput | $0 | – | -70,000 | -100.0% | -1.92% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -104,550 | -100.0% | -2.10% | – |
| TSRO | Exit | TESARO INCput | $0 | – | -50,000 | -100.0% | -2.15% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -36,000 | -100.0% | -2.80% | – |
| PFE | Exit | PFIZER INCput | $0 | – | -180,000 | -100.0% | -3.24% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -75,000 | -100.0% | -3.32% | – |
| JNJ | Exit | JOHNSON & JOHNSONput | $0 | – | -55,000 | -100.0% | -3.41% | – |
| NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -847,127 | -100.0% | -4.02% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -61,000 | -100.0% | -7.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS ORD | 24 | Q4 2023 | 8.3% |
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 19 | Q1 2024 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| THE CIGNA GROUP | 17 | Q2 2024 | 11.0% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 14, 2024 | 280,000 | 7.5% |
| Gracell Biotechnologies Inc. | February 14, 2024 | 25,007,900 | 5.2% |
| Modular Medical, Inc. | February 14, 2024 | 2,110,260 | 10.0% |
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.